Northwestern Medicine scientists have discovered a way to regenerate damaged heart muscle cells in mice, a development that may provide a new avenue for treating congenital heart defects in children ...

Cardiovascular disease continues to lead as the primary cause of death across the globe, taking millions of lives every year. Damage caused by these diseases is particularly difficult to repair, since ...

BACKGROUND: Heart failure with reduced ejection fraction (HFrEF) is characterized by impaired contractility and high ...

METiS TechBio (7666.HK), a global leader in AI-powered drug delivery innovation, today announced that new preclinical data ...

Novel technology returns cardiomyocytes to a stem cell-like state to promote their proliferation and regeneration in an in vitro study. Researchers at the University of Houston (TX, USA) have ...

The alternative text for this image may have been generated using AI. That heart remuscularization is feasible was demonstrated more than 20 years ago in mice using transplanted fetal mouse ...

“For decades, researchers have been trying to find the specialized cells that make new muscle cells in the adult heart, and we think that we have found that cell,” Hesham Sadek, the senior author of ...

To investigate the role of KIF13B in SICD, a research team led by Prof. Xunde Xian from Peking University conducted a series ...

Treatment options for congenital heart disease are limited by the relative inability of mature cardiac muscle cells (cardiomyocytes) to generate new cardiomyocytes through proliferation after birth.

The heart is like a high-octane engine. Fueled by fatty acids, cardiomyocytes have abundant mitochondria to rev up ATP production through oxidative phosphorylation and keep the engine humming. However ...